Workflow
眼科医疗器械
icon
Search documents
越秀:“三位一体”机制让营商环境“优”无止境
Guang Zhou Ri Bao· 2025-07-25 09:07
Core Viewpoint - Guangzhou's Yuexiu District has become a hub for pharmaceutical research and development, driven by continuous improvements in governance and business environment optimization [1][2]. Group 1: Industry Development - Yuexiu District has established itself as a leading area for clinical trials and has attracted major international CROs, with 15 top-tier hospitals and 5 national key laboratories in the biopharmaceutical sector [2][3]. - The district is focusing on the biopharmaceutical and health industry as part of Guangzhou's "12218" modern industrial system, promoting the integration of production, city, and talent [2][3]. Group 2: Economic Impact - The biopharmaceutical industry in Yuexiu is projected to exceed 40 billion yuan in added value by 2024, ranking second in the city, indicating a significant increase in industrial cluster capabilities [3]. - The transformation of the old properties in the district into a vibrant biopharmaceutical and health industry hub has attracted over 30 related enterprises, including CROs and innovative drug research firms [3][4]. Group 3: Policy and Support - Yuexiu District is committed to enhancing its service capabilities for enterprises by implementing targeted policies based on feedback from businesses and hospitals, ensuring effective support for talent development and corporate growth [3][4]. - The district has actively engaged in the organization of industry conferences, providing personalized services to participants, which has been well-received by industry leaders [5]. Group 4: Infrastructure and Resources - The district is improving its physical infrastructure by revitalizing properties around its major hospitals, converting spatial constraints into advantages for high-density development [4]. - Yuexiu is facilitating the flow of various resources, including policy, talent, and financial support, to foster innovation and entrepreneurship in the biopharmaceutical sector [4].